• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.70%

    Osiris Therapeutics, Inc. (OSIR)

    -NasdaqGM
    14.94 Up 0.07(0.47%) Dec 26, 4:00PM EST
    Add to Portfolio
    Prev Close:14.87
    Open:14.93
    Bid:7.21 x 100
    Ask:N/A
    1y Target Est:16.50
    Beta:0.14
    Earnings Date:Mar 3 - Mar 9 (Est.)
    Day's Range:14.90 - 15.50
    52wk Range:11.80 - 18.41
    Volume:116,121
    Avg Vol (3m):103,643
    Market Cap:512.74M
    P/E (ttm):10.82
    EPS (ttm):1.38
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OSIR

    Comparison

    Symbol% ChgMkt Cap
    OSIRUp 0.47%512.74M
    ABTUp 0.33%69.04B
    BIIBUp 0.44%80.86B

    Key Statistics

    Forward P/E (1 yr):124.50
    P/S (ttm):10.49
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.02
    Quarterly EPS Est (Dec-14) :0.02
    Mean Recommendation*:3.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Osiris Therapeutics, Inc., a stem cell company, focuses on the development and marketing products to treat medical conditions in wound care, orthopedic, and sports medicine markets. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback